> ## Content Index
> Fetch the complete content index at: https://acentricresearch.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Biotechnology × Energy: Intersection Brief – November 2026
- URL: https://acentricresearch.com/research/biotechnology-energy-brief-2026-11/
- Published: 2026-11-20T20:56:37.000Z
- Updated: 2026-11-20T20:56:37.000Z
- Author: Kevin Meyer
- Tags: intersection-brief, biotechnology-energy

> Acentric Research is produced with AI tools under human review. It is affiliated with Acentric Capital, a private investment group whose members may hold positions in companies discussed. The authors are not financial professionals, and nothing here is investment advice or a recommendation to buy or sell any security. AI analysis can be wrong; check every claim against its cited source.

This Brief is an initial scan, not a full investigation. The method and scores behind it are in [Biotechnology × Energy in the Landscape Report](https://acentricresearch.com/research/landscape-2026-11/#biotechnology-energy).

### Overview

Pacemakers and similar implanted devices have run on batteries. A review of the field says conventional batteries limit how long a device lasts and how small it can be, and that they must be replaced or recharged, which raises concerns for patient safety, healthcare cost and device reliability. \[1\] This pair covers energy sources built for that problem: harvesting power from the body’s own motion, heat or chemistry, and sending power into the body from outside. In this Brief, biotechnology means anything biological or medical that affects human health, and energy means a new source or method of power that solves a real problem, here at the scale of a device inside the body.

The pair has one Junction, power harvesting for implanted medical devices. The sources opened date from 2019 to 2026: one news article, one open-access research paper and two reviews, of which only the abstracts were read. They describe tests in animals and a field of wireless power that one 2026 review says is being commercialized. Later developments, and any company work, were not searched.

### Current state

**What each field does for the other.** Energy research offers new ways to power a device that cannot easily be reached once implanted. Biology supplies the energy and the constraints: the heart’s motion, body heat, glucose in the blood, and the tolerance of tissue. The 2025 review lists the approaches under study: electromagnetic harvesting, ultrasound wireless power transfer, energy from tissue motion and heartbeats, thermoelectric generators that use body temperature differences, and biofuel cells that use glucose. \[1\]

**Who is working on it.** The sources opened describe university research groups. Engineers at Dartmouth College built a thin-film piezoelectric harvester designed to sit on a pacemaker lead and convert the heart’s motion into electricity. \[2\] A research team in China built a capsule pacemaker that draws power from heartbeat motion by triboelectric effect, the generation of charge by contact between materials. \[3\] The sources opened describe only university groups; company work was not searched. The Landscape Report found no verified funded programme or capital event and no harvester-powered implant in FDA’s device databases. \[4\]

**Wireless power.** Power can instead be sent in through the skin. A 2026 review says implants with wireless power are employed in applications such as deep brain stimulators, capsule endoscopes, pacemakers and cardiac monitors, “which are being commercialized”, and names efficiency, data rate and circuit complexity as its design problems. \[5\]

**The Junction.**

- **Power harvesting for implanted medical devices.** Devices that make their own power from the body, with wireless and beamed power in scope. Tested in animals; no human trial found. See the [Junction Brief](https://acentricresearch.com/research/implant-power-harvesting-brief-2026-11/). \[3\]\[2\]

**What was left out.** The Landscape Report excluded one niche for this pair: health-care facility energy use, together with matches that used “energy” in an unrelated sense. It is general energy efficiency, and radiopharmaceuticals are not energy generation. \[4\]

**How far it has come.** Harvesting: demonstrated in live animals, including a pacemaker that paced a pig’s heart for three weeks. Wireless power: one 2026 review says applications of implants with wireless power are being commercialized; no product or approval was checked. \[3\]\[4\]\[5\]

### Opportunities

The Dartmouth researchers say their design can be miniaturized and integrated into existing pacemakers, and that it could eventually power other implantable devices. \[2\] The authors of the swine study say their device may overcome the energy shortcomings of implantable pacemakers and other devices for therapy and sensing, and say a constant energy supply would avoid the risk of a replacement operation when a battery runs down. \[3\] The 2025 review says harvesting from the body offers access to energy from movement that does not run out, and notes dual functionality. \[1\]

### Challenges

- **Power output.** In the swine study the capsule’s open-circuit voltage was about 6.0 volts and its short-circuit current about 0.2 microamps. The authors report a maximum power density of 2,200 milliwatts per cubic metre at a 100-megohm load for the harvesting unit, from bench measurements. \[3\]
- **Scale-up and human testing.** One Dartmouth researcher said commercialization was likely to take a while; the article adds that more animal experiments would be needed before human tests. \[2\] The swine study followed its animals for three weeks. \[3\]
- **Trade-offs.** The 2025 review describes its aim as overcoming trade-offs between biocompatibility, power density and clinical viability. \[1\]
- **Wireless link design.** For power sent from outside, the 2026 review names power-transfer efficiency, data rate, power use and circuit complexity as problems to be solved together. \[5\]

### Data sources

The sources below are where a deeper investigation would look; those marked “listed” were not searched for this Brief.

- **FDA device databases**, for cleared or approved implants and their power sources. \[6\]
- **ClinicalTrials.gov**, for human studies of self-powered implants. \[7\]
- **Europe PMC**, for research papers and reviews. \[8\]
- **SEC EDGAR**, for filings of implant makers. \[9\]
- No registry of research groups or companies working on body-powered implants was found.

### Changelog

- 2026-11-19: First published.

### Sources

1. Liang, Y. et al., “Sustainable power solutions for next-generation medical devices”, Materials Today Bio, 2025-07-04 (review; abstract read via Europe PMC). [doi.org](https://doi.org/10.1016/j.mtbio.2025.102055?ref=acentricresearch.com) (accessed 2026-11-19)
2. Digital Trends, “Energy-harvesting gizmo powers medical implants using your own heartbeat”, 2019-02-07 (trade press quoting the Dartmouth researchers). [digitaltrends.com](https://digitaltrends.com/cool-tech/dartmouth-college-heart-power-harvesting?ref=acentricresearch.com) (accessed 2026-11-19)
3. Liu, Z. et al., “A self-powered intracardiac pacemaker in swine model”, Nature Communications, 2024-01-13 (open-access paper; full text read via Europe PMC). [doi.org](https://doi.org/10.1038/s41467-023-44510-6?ref=acentricresearch.com) (accessed 2026-11-19)
4. Acentric Research, Landscape Report, November 2026, Biotechnology × Energy section and Exclusions. [acentricresearch.com](https://acentricresearch.com/research/landscape-2026-11/#biotechnology-energy) (accessed 2026-11-19)
5. Ullah, N. et al., “Wireless Power and Data Transfer over Inductive Links for Biomedical Applications: Recent Advances, Challenges, and Limitations”, Micromachines, 2026-08-24 (review; abstract read via Europe PMC). [doi.org](https://doi.org/10.3390/mi17090998?ref=acentricresearch.com) (accessed 2026-11-19)
6. US Food and Drug Administration, device databases (premarket approval, 510(k), De Novo). [accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ref=acentricresearch.com)(listed as a data source; not searched for this Brief)
7. ClinicalTrials.gov, US National Library of Medicine. [clinicaltrials.gov](https://clinicaltrials.gov/?ref=acentricresearch.com) (listed as a data source; not searched for this Brief)
8. Europe PMC, literature search. [europepmc.org](https://europepmc.org/?ref=acentricresearch.com) (listed as a data source; the records cited here were opened)
9. SEC EDGAR, full-text search. [sec.gov](https://www.sec.gov/edgar/search/?ref=acentricresearch.com) (listed as a data source; not run for this Brief)